Eris Lifesciences Ltd. - Research Center
540596 ERIS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 13.58 | 13.75 | 13.75 | 13.75 | 0.14 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 1,286.12 | 1,142.26 | 854.43 | 560.85 | 305.21 |
| Loan funds | |||||
| Secured loans | - | - | 273.69 | - | - |
| Unsecured loans | - | - | - | - | - |
| Total | 1,299.70 | 1,156.01 | 1,141.87 | 574.60 | 305.35 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 669.50 | 536.14 | 527.02 | 111.92 | 107.48 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 68.86 | 52.29 | 37.27 | 20.15 | 42.68 |
| Net block | 600.64 | 483.85 | 489.75 | 91.78 | 64.79 |
| Capital work-in-progress | 4.37 | 2.73 | - | - | - |
| Investments | 320.30 | 580.47 | 545.60 | 380.61 | 206.33 |
| Net current assets | |||||
| Current assets, loans & advances | 557.81 | 403.33 | 334.63 | 184.30 | 131.00 |
| Less : current liabilities & provisions | 183.43 | 314.37 | 228.11 | 82.09 | 96.77 |
| Total net current assets | 374.39 | 88.96 | 106.52 | 102.21 | 34.23 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 1,299.70 | 1,156.01 | 1,141.87 | 574.60 | 305.35 |
| Notes: | |||||
| Book value of unquoted investments | 319.96 | 578.54 | 363.61 | 301.61 | 204.83 |
| Market value of quoted investments | 0.34 | 1.93 | 1.76 | 1.62 | 1.16 |
| Contingent liabilities | 15.81 | 15.29 | 14.12 | 12.90 | - |
| Number of equity sharesoutstanding (Lacs) | 1357.81 | 1375.20 | 1375.00 | 1375.00 | 1.38 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis